APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters
$4,950Single user · USD · Market Analysis & ForecastExplore product: MagaldrateCompare research options for Magaldrate

Pharma & Healthcare

Elapegademase-lvlr

Revcovi (elapegademase-lvlr) is a new enzyme replacement therapy indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.

Types
Revcovi · Strimvelis · Adagen
Applications
Pediatric · Adult

5 editions22 December 2025

View 5 research editions

Pharma & Healthcare

Haemophilus Influenzae Type B Vaccine

Types
Liquid Combination HIB · Liquid Monovalent HIB · Lyophilized Combination HIB
Applications
Pharmaceutical and Biotechnology Companies · Hospital · Research Institutions

5 editions22 December 2025

View 5 research editions

Pharma & Healthcare

Antiasthmatic Drug

Types
Anti-allergic Antiasthmatic · Anti-inflammatory Antiasthmatic · Bronchodilators
Applications
Hospital · Clinic · Other

5 editions2 January 2026

View 5 research editions
APO Research, Inc.